GSK buys HIV medicines for $1.4bn

vendredi 18 décembre 2015

GlaxoSmithKline ends a frenetic week for the pharmaceutical sector with a $1.4bn takeover of HIV drug development assets from Bristol-Myers Squibb. GSK buys HIV medicines for $1.4bn

0 commentaires:

Enregistrer un commentaire